tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals, Inc. (DE:4XC1)
NASDAQ:4XC1
Germany Market

KalVista Pharmaceuticals (4XC1) Balance Sheet

Compare
0 Followers

KalVista Pharmaceuticals Balance Sheet

KalVista Pharmaceuticals's total assets for Q2 2026 were $339.93M, an increase of 57.74% from the previous quarter. DE:4XC1 total liabilities were $322.93M for the fiscal quarter, a 84.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Apr 25Apr 24Apr 23Apr 22Apr 21
Total Assets
$ 250.77M$ 235.40M$ 183.20M$ 203.88M$ 272.01M
Total Liabilities
$ 155.38M$ 28.82M$ 22.18M$ 18.79M$ 14.82M
Total Equity Gross Minority
$ 95.39M$ 206.58M$ 161.03M$ 185.09M$ 257.19M
Other Metrics
Currency in USD

KalVista Pharmaceuticals Debt to Assets